Free weight-loss visit planner. Bring your questions to your next appointment.

Injection

Compounded Semaglutide injection

An ingredient may appear in several products. Start with the prescription name and the reason your clinician is considering it.

Browse guides
Illustrative Pulse+ Semaglutide injection bottle

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.

Match the name to the indication

Semaglutide is a GLP-1 receptor agonist. FDA-approved injectable products have specific uses and prescribing information. Ask which label applies and where you can read the patient information for that product.

Talk through the practical details

A product photograph cannot tell you what your pharmacy would dispense. Ask about the packaging, the supplies that come with it and who could demonstrate the actual device if one is prescribed.

Agree on a follow-up plan

Ask what changes the clinician would want to hear about before the next review and how to reach the team. If a compounded injection is discussed, ask for its source. Compounded drugs do not undergo FDA review for safety, effectiveness and quality before marketing.

Explore other injectables

Illustrative Pulse+ Tirzepatide injection packaging

Injection

Compounded Tirzepatide injection

Learn which product your clinician is discussing, why they are considering it and how they would review your progress.

Learn more
Illustrative Pulse+ Sermorelin injection packaging

Growth hormone–releasing peptide

Compounded Sermorelin injection

A separate hormone-related topic. Understanding why sermorelin came up is the first question to bring to a clinician.

Learn more

Pulse+ visit planner

Prepare for your visit

Choose what matters to you. Take your questions to a conversation with your clinician.

What would you like to discuss?

Your selections stay in this tab until you close or reload the page.